The EMRA offices will be closed for the upcoming holidays from Wednesday, December 24, 2025 until Monday, January 5, 2026.

News & Notes in Emergency Medicine

Med Student Participates in EMRA Advocacy Initiative
As part of her EMRA/ACEP Medical Student Health Policy Elective participation, EMRA medical student member Jackie King attended an event for Rep. Kim Schrier, MD (D-WA), in Washington, DC. At the event, King was able to meet special guest Rep. Nancy Pelosi (D-CA).

Med Student 1.jpg        Med Student 2.jpg
Medical student Jackie King (left, in left-side photo) with Rep. Kim Schrier, MD (D-WA). King (right, in right-side photo) with Nancy Pelosi (D-CA).

The EMRA/ACEP Medical Student Health Policy Elective provides EM-bound medical students the opportunity to research legislative issues pertinent to the practice of EM. Participants gain hands-on experience as advocates for the specialty through interactions with local, state, and federal legislators.

ABEM Elects New Board Members
The American Board of Emergency Medicine (ABEM) recently elected 2 new physician members: John T. Finnell, MD, MSc, and Melissa A. Platt, MD.

Dr. Finnell is a professor of clinical emergency medicine in the Department of Emergency Medicine at the Indiana University School of Medicine. He practices as a nocturnist at Eskenazi Health.

Dr. Platt is a professor and former program director in the Department of Emergency Medicine and associate dean of graduate medical education at the University of Louisville School of Medicine. She practices clinically at the UofL Hospital.

Related Articles

Critical Care Alert: A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest

Every minute counts for long-term outcomes in out-of-hospital cardiac arrest. Does the route of administration for lifesaving medications play a role? This EMRA Critical Care Alert dives into the PARA

Pseudo-Subarachnoid Hemorrhage Following Cervical Medial Branch Block Using Gadolinium-Based Contrast: A Case Report and Review of the Literature

This case report explores the evidence behind recognizing and treating conditions caused by gadolinium-based contrast agents — including pseudo-subarachnoid hemorrhage.
CHAT NOW
CHAT OFFLINE